Literature DB >> 26345741

TGF-β1 polymorphisms and familial aggregation of liver cancer in Guangxi, China.

P Q Wan1, J Z Wu2, L Y Huang1, J L Wu1, Y H Wei1, Q Y Ning1.   

Abstract

The goal of present study was to investigate the relationship between polymorphisms of TGF-β1 and familial aggregation of liver cancer in Guangxi Zhuang, Han, and Yao populations. We conducted a population-based case-control family study of liver cancer in Guanxi, China. A total of 214 individuals from 37 case families were surveyed for polymorphisms in TGF-β1. We genotyped six functional TGF-β1 polymorphisms: rs1800469, rs2241715, rs2241716, rs11466345, rs8105161, and rs747857. Levels of TGF-β1, hepatitis B surface antigen, and anti-hepatitis C virus in all serum samples were detected using the enzyme-linked immunoassay method, and presence of hepatitis B virus (HBV) DNA was determined using polymerase chain reaction amplification. A standardized questionnaire was used to collect information from subjects, including alcohol consumption, smoking, eating, and water drinking habits. The results were compared with those from 214 control individuals. The results showed that the TGF-β1 genotypes rs1800469, rs2241715, rs2241715, and rs8105161 were more frequent in patients than in controls. The risk factors for familial aggregation of liver cancer in Guangxi were determined, from high to low, to be: drinking sugared beverages > alcohol consumption > HBV DNA-positive > rs1800469 TT homozygous genotype > rs2241715 TT homozygous genotype. The results suggested that TGF-β1 rs1800469 TT and rs2241715 TT homozygote genotypes represent the genetic factors underlying familial clustering of liver cancer in Guangxi, and that drinking water use, alcohol consumption, and testing positive for HBV DNA are the main environmental factors contributing to familial aggregation of liver cancer in Guangxi.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345741     DOI: 10.4238/2015.July.27.3

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  Inherited alterations of TGF beta signaling components in Appalachian cervical cancers.

Authors:  Thomas J Knobloch; Juan Peng; Erinn M Hade; David E Cohn; Mack T Ruffin; Michael A Schiano; Byron C Calhoun; William C McBee; Jamie L Lesnock; Holly H Gallion; Jondavid Pollock; Bo Lu; Steve Oghumu; Zhaoxia Zhang; Marta T Sears; Blessing E Ogbemudia; Joseph T Perrault; Logan C Weghorst; Erin Strawser; Cecilia R DeGraffinreid; Electra D Paskett; Christopher M Weghorst
Journal:  Cancer Causes Control       Date:  2019-08-21       Impact factor: 2.506

2.  A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Authors:  Carolina Martínez-Laperche; Elena Buces; M Carmen Aguilera-Morillo; Antoni Picornell; Milagros González-Rivera; Rosa Lillo; Nazly Santos; Beatriz Martín-Antonio; Vicent Guillem; José B Nieto; Marcos González; Rafael de la Cámara; Salut Brunet; Antonio Jiménez-Velasco; Ildefonso Espigado; Carlos Vallejo; Antonia Sampol; José María Bellón; David Serrano; Mi Kwon; Jorge Gayoso; Pascual Balsalobre; Álvaro Urbano-Izpizua; Carlos Solano; David Gallardo; José Luis Díez-Martín; Juan Romo; Ismael Buño
Journal:  Blood Adv       Date:  2018-07-24

Review 3.  Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review.

Authors:  Carolina Alvarez; Eduardo Gotuzzo; Anne-Mieke Vandamme; Kristien Verdonck
Journal:  Front Microbiol       Date:  2016-10-28       Impact factor: 5.640

4.  Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population.

Authors:  Xue-Hong Liang; Liucheng Rong; Guangsheng He; Hailong He; Shengyun Lin; Yan Yang; Yao Xue; Yongjun Fang
Journal:  Ann Hematol       Date:  2016-12-09       Impact factor: 3.673

5.  Polymorphisms of -800G/A and +915G/C in TGF-β1 gene and lung cancer susceptibility.

Authors:  Qing-Guo Di; Bao-Hua Sun; Ming-Ming Jiang; Jun-Feng Du; Zhi-Tao Mai; Xin Zhang; Li-Rong Zhou; Yu-Min Chi; Jing Lv
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

6.  Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.

Authors:  Wei-Qun Lu; Ji-Liang Qiu; Zhi-Liang Huang; Hai-Ying Liu
Journal:  Oncotarget       Date:  2016-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.